the house has passed an order extending the public health committee's reporting deadline for cusack's bill...
.
..
.
.- . taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.